Stable supply of high-quality products (IP5, IP10); direct sales from the peptide manufacturer with door-to-door delivery.
TDS
58013-09-5
Pharmaceutical
99.5%
SHENZHEN
KSD
vial/kit
2026-11-23
Semaglutide
-
Product Description
-
Seller Information
-
DescriptionResearch & Reference Note
Stable supply of high-quality products (IP5, IP10); direct sales from the peptide manufacturer with door-to-door delivery. is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Authoritative sourcesDisclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals
Certificates-
TDS
Basic Info-
Product Name:
1-(2-ethoxy-2-pyridin-3-ylethyl)-4-(2-methoxyphenyl)piperazine
Other Name:1-(2-ethoxy-2-(3'-pyridyl)ethyl)-4-(2'-methoxyphenyl)piperazine;IP 66;IP-66;58013-09-5;IP-66;(+/-)-IP-66;(+/-)-IP 66;(+/-)-IP66;IP 66;IP66;1-[2-ethoxy-2-(pyridin-3-yl)ethyl]-4-(2-methoxyphenyl)piperazine;SCHEMBL3628739;DTXSID60973600;1-(2-ethoxy-2-pyridin-3-ylethyl)-4-(2-methoxyphenyl)piperazine;1-(2-Ethoxy-2-(3'-pyridyl)ethyl)-4-(2'-methoxyphenyl)piperazine;Piperazine, 1-(2-ethoxy-2-(3-pyridinyl)ethyl)-4-(2-methoxyphenyl)-
CAS No.:58013-09-5
Molecular Formula:C20H27N3O2
InChIKeys:FFKRVMYEUOOFBT-UHFFFAOYSA-N
Molecular Weight:341.4 g/mol
Exact Mass:341.21032711 g/mol
Categories:
Characteristics-
PSA:
37.8 Ų
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Semaglutide
-
Location:
Licheng District, Jinan City, Shandong Province
-
Payment Terms:
100% TT in advance
-
Average lead Time:
14
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
5-10
-
Year of Establishment:
2026
-
Certifications:
Retatrutide coa
">KSD -
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
KSD